ResMed | RMD - Interest Expense On Debt


ResMed reported $8.79M in Interest Expense on Debt for its fiscal quarter ending in September of 2025.





Interest Expense On Debt Change Date
Ansell USD 20.6M 300K Dec/2025
Artivion USD 5.53M 589K Dec/2025
AtriCure USD 1.33M 17K Sep/2025
Baxter International USD 58M 14M Sep/2025
Cochlear AUD 6.3M 3.65M Dec/2025
Cooper Companies USD 22.4M 2M Dec/2025
CSL USD 215M 111M Dec/2025
Dexcom USD 4.7M 0 Sep/2025
Edwards Lifesciences USD 38.6M 1.2M Sep/2025
Fisher Paykel Healthcare NZD 5.5M 700K Dec/2025
Globus Medical USD 17K 5.1B Dec/2025
Haemonetics USD 7.21M 3.14M Sep/2025
Hologic USD 27.6M 1000K Dec/2025
Idexx Laboratories USD 10.08M 1.24M Sep/2025
Inogen 1.03M 384K Mar/2025
Insulet USD 9.2M 2.2M Dec/2025
Integra LifeSciences USD 23.67M 953K Dec/2025
Intuitive Surgical USD 19.35B 811.4M Sep/2025
Masimo USD 7.5M 1.3M Dec/2025
Medtronic USD 181M 0 Dec/2025
Philips EUR 109M 31M Dec/2025
Ramsay Health Care AUD 300.6M 15.5M Dec/2025
ResMed USD 8.79M 14.55M Sep/2025
Sigma Healthcare AUD 7.97M 365K Jan/2024
Sonic Healthcare AUD 86.91M 43.94M Dec/2024
Steris USD 14.9M 0 Dec/2025
Teleflex USD 28.15M 3.69M Dec/2025
Thermo Fisher Scientific USD 365M 18M Dec/2025